RxDoctor Payments Data

Robert Sarro, MD

Dermatology · Boca Raton, FLNPI 1164403192

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $18,596 of the $26,971 with a category attached, or 68.9%. Sun Pharmaceutical Industries Inc. accounts for 68.6% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $10,146 and has fallen 89.6% since, to $1,053 in 2025. Among dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,971in general payments, 2019–2025

Across 228 payments — averaging $118.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$19K
  • Promius Pharma LLC$2K
  • UCB, Inc.$1K
  • AbbVie$890
  • Sanofi$822
  • Medimetriks Pharmaceuticals, Inc.$700
  • plus $3K from 18 others
$17,604in research payments, 2019–2025

Across 14 payments — averaging $1257.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$15K
  • Janssen Research & Development, LLC$2K

What the payments were for

  • Consulting fees$1,8807%
  • Speaking & faculty fees$18,59669%
  • Grants$2201%
  • Travel & lodging$5362%
  • Food & beverage$5,39320%
  • Education$3471%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,971 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024
$1,426,332
Medicare patients
1,193
Services billed
16,514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab13$94,390
Dupixent SyringeDupilumab12$44,636
Clobetasol Propionate216$9,463
Betamethasone Dipropionate123$4,831
Betamethasone Valerate125$3,243
Metronidazole52$2,099
Fluorouracil40$2,055
Ketoconazole78$1,751
Doxycycline Hyclate61$1,675
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip71$1,520
Imiquimod70$1,505
Triamcinolone Acetonide135$1,334
ValacyclovirValacyclovir Hcl56$1,186
Tretinoin13$934
Clindamycin Phosphate41$890

Paid to pharmacies, not to this prescriber.

Other dermatology in Boca Raton

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →